MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$14,359K
Net Income
-$19,501K
Net Profit Margin
-135.81%
EPS
-$0.67
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenue
14,359
17,159
18,615
15,464*
Research and development
22,126
19,443
20,859
23,827*
General and administrative
9,469
9,568
9,009
11,856*
Total operating expenses
31,595
29,011
29,868
35,682*
Loss from operations
-17,236
-11,852
-11,253
-20,218*
Interest expense
4,130
3,316
3,083
2,653*
Interest and investment income, net
1,901
2,084
2,422
2,577*
Change in fair value of series 1 nonconvertible preferred stock
-
-
-
10*
Total other (expense) income, net
-2,229
-1,232
-661
-67*
Loss before income taxes
-19,465
-13,084
-11,914
-20,286*
Income tax (expense) benefit
36
7
24
254*
Net loss
-19,501
-13,091
-11,938
-20,540
Basic EPS
-0.67
-0.45
-0.42
0.481
Diluted EPS
-0.67
-0.45
-0.42
0.481
Basic Average Shares
29,090,000
29,040,000
28,748,000
-42,667,992
Diluted Average Shares
29,090,000
29,040,000
28,748,000
-42,667,992
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$19,501K
(-6.83%↓ Y/Y)
Loss before income
taxes
-$19,465K
(-6.80%↓ Y/Y)
Income tax (expense)
benefit
$36K
(24.14%↑ Y/Y)
Loss from operations
-$17,236K
(8.77%↑ Y/Y)
Total other (expense)
income, net
-$2,229K
(-434.18%↓ Y/Y)
Total revenue
$14,359K
(-21.60%↓ Y/Y)
Interest and investment
income, net
$1,901K
(-16.81%↓ Y/Y)
Total operating
expenses
$31,595K
(-15.08%↓ Y/Y)
Interest expense
$4,130K
(155.25%↑ Y/Y)
Research and development
$22,126K
(-18.68%↓ Y/Y)
General and
administrative
$9,469K
(-5.28%↓ Y/Y)
Buy us a coffee
ENANTA PHARMACEUTICALS INC (ENTA)
ENANTA PHARMACEUTICALS INC (ENTA)